Parkinson's Disease and Tea: A Quantitative Review

被引:0
作者
Barranco Quintana, Jose Luis [1 ]
Farouk Allam, Mohamed [1 ]
Serrano Del Castillo, Amparo [1 ]
Fernandez-Crehuet Navajas, Rafael [1 ]
机构
[1] Univ Cordoba, Fac Med, Dept Prevent Med & Publ Hlth, E-14004 Cordoba, Spain
关键词
Parkinson's disease; tea; systematic review; meta-analysis; ENVIRONMENTAL RISK-FACTORS; GREEN TEA; CIGARETTE-SMOKING; CAFFEINE INTAKE; POLYPHENOLS; CONSUMPTION; COFFEE; 6-HYDROXYDOPAMINE; METAANALYSIS; INHIBITION;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Purpose: To evaluate the risk of PD associated with tea consumption. Material and Methods: We reviewed all observational studies that evaluated the association between PD risk and tea consumption. Only, 12 studies were identified: 11 case-control and 1 cohort. These studies were carried out between 1981 and 2003. The studies represented different populations from 3 continents; North America, Europe and Asia. The 3 studies from Asia were case-control studies of Chinese populations. Results: There was a clear protective effect of tea consumption in the pooled risk estimate [OR: 0.83 (95% confidence interval 0.74 to 0.92)] with 2215 cases and 145578 controls. However, the homogeneity test was significant (p value of 0.008), denoting heterogeneity across the pooled studies. Pooled analysis applying the random effect model was OR: 0.81 with 95% confidence interval nearly overlapping unity (95% confidence interval 0.67 to 0.98). Tea consumers versus non-consumers in Chinese populations had pooled OR of 0.73 with 95% confidence interval 0.60 to 0.90 (470 cases and 623 controls). The p value of homogeneity test was 0.96, denoting homogeneity across the pooled 3 studies. Conclusion: Tea consumption can protect against PD and this protective effect is clearer in Chinese populations. The low rate of tea consumption among persons with PD should provide us many valuable insights into the nature of the illness.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 53 条
[1]   Risk of dementia in Parkinson's disease - A community-based, prospective study [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Lolk, A ;
Nielsen, H ;
Kragh-Sorensen, P .
NEUROLOGY, 2001, 56 (06) :730-736
[2]   Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1β-induced expression of matrix metalloproteinase-1 and-13 in human chondrocytes [J].
Ahmed, S ;
Wang, NZ ;
Lalonde, M ;
Goldberg, VM ;
Haqqi, TM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02) :767-773
[3]   Smoking and Parkinson's disease: Explanatory hypothesis [J].
Allam, MF ;
Del Castillo, AS ;
Navajas, RFC .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2002, 112 (07) :851-854
[4]  
[Anonymous], MOV DISORD
[5]   Prospective study of caffeine consumption and risk of Parkinson's disease in men and women [J].
Ascherio, A ;
Zhang, SMM ;
Hernán, MA ;
Kawachi, I ;
Colditz, GA ;
Speizer, FE ;
Willett, WC .
ANNALS OF NEUROLOGY, 2001, 50 (01) :56-63
[6]   Smoking, alcohol, and coffee consumption preceding Parkinson's disease - A case-control study [J].
Benedetti, MD ;
Bower, JH ;
Maraganore, DM ;
McDonnell, SK ;
Peterson, BJ ;
Ahlskog, JE ;
Schaid, DJ ;
Rocca, WA .
NEUROLOGY, 2000, 55 (09) :1350-1358
[7]   Genetic and environmental risk factors for Parkinson's disease in a Chinese population [J].
Chan, DKY ;
Woo, J ;
Ho, SC ;
Pang, CP ;
Law, LK ;
Ng, PW ;
Hung, WT ;
Kwok, T ;
Hui, E ;
Orr, K ;
Leung, MF ;
Kay, R .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (05) :781-784
[8]   Epidemiologic approaches to the study of Parkinson's disease etiology [J].
Checkoway, H ;
Nelson, LM .
EPIDEMIOLOGY, 1999, 10 (03) :327-336
[9]   Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake [J].
Checkoway, H ;
Powers, K ;
Smith-Weller, T ;
Franklin, GM ;
Longstreth, WT ;
Swanson, PD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (08) :732-738
[10]   The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease [J].
Costa-Mallen, P ;
Checkoway, H ;
Fishel, M ;
Cohen, AW ;
Smith-Weller, T ;
Franklin, GM ;
Swanson, PD ;
Costa, LG .
NEUROSCIENCE LETTERS, 2000, 278 (1-2) :33-36